Michael O'Dwyer to Tumor Microenvironment
This is a "connection" page, showing publications Michael O'Dwyer has written about Tumor Microenvironment.
Connection Strength
0.324
-
The Tumour Glyco-Code: Sialylation as a Mediator of Stromal Cell Immunosuppression in the Tumour Microenvironment. Eur J Immunol. 2025 Jul; 55(7):e70000.
Score: 0.214
-
Cyclophosphamide alters the tumor cell secretome to potentiate the anti-myeloma activity of daratumumab through augmentation of macrophage-mediated antibody dependent cellular phagocytosis. Oncoimmunology. 2021 01 25; 10(1):1859263.
Score: 0.039
-
IBL-202 is synergistic with venetoclax in CLL under in vitro conditions that mimic the tumor microenvironment. Blood Adv. 2020 10 27; 4(20):5093-5106.
Score: 0.039
-
The dual inhibitor of the phosphoinositol-3 and PIM kinases, IBL-202, is effective against chronic lymphocytic leukaemia cells under conditions that mimic the hypoxic tumour microenvironment. Br J Haematol. 2018 09; 182(5):654-669.
Score: 0.033